186
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver

, MD, , MD, PhD, , MD, , MD, , MD, PhD, , MD, MSc, PhD, , PhD, , PhD & , MD, PhD show all
Pages 366-377 | Received 21 Feb 2017, Accepted 22 May 2017, Published online: 23 Jun 2017

REFERENCES

  • Kucera O, Cervinkova Z. Experimental models of non-alcoholic fatty liver disease in rats. World J Gastroenterol. 2014;20(26):8364–8376.
  • Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238:843–852.
  • Jin LM, Liu YX, Zhou L, et al. Ischemic preconditioning attenuates morphological and biochemical changes in hepatic ischemia/reperfusion in rats. Pathobiol. 2010;77:136–146.
  • Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545–1559.
  • Yadav SS, Sindram D, Perry DK, et al. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatol. 1999;30:1223–1231.
  • Breitenstein S, Apestegui C, Petrowsky H, et al. ‘State of the art’ in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg. 2009;33:797–803.
  • DuBray BJ, Gunter K, Hassan H, et al. Absence of BH3-only proteins mitigates accentuation of hepatic ischemia-reperfusion injury caused by steatosis. J Surg Res. 2012;172(2):302–303.
  • Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–285.
  • Mokuno Y, Berthiaume F, Tompkins RG, et al. Technique for expanding the donor liver pool: heat shock preconditioning in a rat fatty liver model. Liver Transpl. 2004;10:264–272.
  • Selzner N, Selzner M, Jochum W, et al. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. J Hepatol. 2003;39:55–61.
  • Hilden M, Christoffersen P, Juhl E, et al. Liver histology in a normal population-examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol. 1977;12:593–597.
  • Veteläinen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg. 2007;245:44–50.
  • Centers for Disease Control and Prevention: Overweight and obesity. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/. Accessed December 13, 2006.
  • Berson A, De Beco V, Letteron P, et al. Steatohepatitis inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998;114:764–774.
  • Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. J Hepatol. 1997;26:43–53.
  • de Meijer VE, Kalish BT, Puder M, et al. Steatosis is a risk factor for complications and mortality following major hepatic resection: a systematic review and meta-analysis. J Surg Res. 2010;158(2):175.
  • Park SW, Kang J-W, Lee S-M. Role of Kupffer cells in ischemic injury in alcoholic fatty liver. J Surg Res. 2014;194(1):91–100.
  • Selzner M, Rüdiger HA, Sindram D, et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatol. 2000;32:1280–1288.
  • Behrns KE, Tsiotos GG, DeSouza NF, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointestinal Surg. 1998;2:292–298.
  • Ploeg RJ, D'Alessandro AM, Knechtle SJ. Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transpl. 1993;55:807.
  • Saidi RF, Chang J, Brooks S, et al. Ischemic Preconditioning and intermittent clamping increase the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Transpl Proc. 2007;39:3010–3014.
  • McCormack L, Petrowsky H, Jochum W, et al. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg. 2007;245(6):923–930.
  • Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990's: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38–46.
  • Tsukada K, Miyazaki T, Kato H, et al. Body fat accumulation and postoperative complications after abdominal surgery. Am Surg. 2004;70:347.
  • Al-Humadi H, Theocharis S, Dontas I, et al. Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases. Dig Dis Sci. 2012;57(12):3168–3177.
  • Chu Μ, Hickey Α, Phillips Α, et al. The impact of hepatic steatosis on hepatic ischemia-reperfusion injury in experimental studies: a systematic review. BioMed Res Int. 2013; Article ID 192029, 12. doi:10.1155/2013/192029
  • DuBray B Jr, Conzen K, Upadhya G, et al. BH3-only proteins contribute to steatotic liver ischemia–reperfusion injury. J Surg Res. 2014;194(2):653–658.
  • Kim Y. Ischemia-reperfusion injury of the human liver during hepatic resection. J Hepatobiliary Pancreat Surg. 2003;10(3):195–199.
  • Hoekstra LT, van Trigt JD, Reiniers MJ, et al. Vascular occlusion or not during liver resection: the continuing story. Dig Surg. 2012;29(1):35–42.
  • Mendes-Braz M, Elias-Miró M, Jiménez-Castro MB, et al. The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotech. 2012, Article ID 298657, 20, doi:10.1155/2012/298657
  • Caraceni P, Domenicali M, Vendemiale G, et al. The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res. 2005;124(2):160–168.
  • McCord JM. Oxygen-derived free radicals in post ischemic tissue injury. N Engl J Med. 1985;312(3):159–163.
  • Hakamada K, Sasaki Μ, Takahashi K, et al. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res. 1997;70(1):12–20.
  • Murry CE, Richard VJ, Reimer KA, et al. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 1990;66:913.
  • Cavalieri B, Perrelli MG, Aragno M, et al. Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. Liver Transpl. 2002;8:990.
  • Koti RS, Yang W, Dashwood MR, et al. Effect of ischemic preconditioning on hepatic microcirculation and function in a rat model of ischemia reperfusion injury. Liver Transpl. 2002;8:1182.
  • Serafin A, Rosello-Catafau J, Prats N, et al. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatol. 2004;39:688.
  • Clavien PA, Yadav S, Sindram D, et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155.
  • Isozaki H, Adam R, Gigou M, et al. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg. 1992;79:310.
  • Horiuchi T, Muraoka R, Tabo T, et al. Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch Surg. 1995;130:754.
  • Peralta C, Closa D, Hotter G, et al. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun. 1996;229:264.
  • Vollmar B, Glasz J, Leiderer R, et al. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol. 1994;145:1421.
  • Liedtke C, Luedde T, Sauerbruch T, et al. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair. 2013;6:19. doi:10.1186/1755-1536-6-19
  • Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol: WJG. 2012;18(19):2300–2308. doi:10.3748/wjg.v18.i19.2300
  • Veteläinen R, van Vliet A, van Gulik TM. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J Gastroenterol Hepatol. 2007;22(9):1526–1533.
  • Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis. 2001;21:89–104.
  • Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006;87:1.
  • Jiang Y, Tang JJ, Wu BQ, et al. The protective effects of different-time-ischemic preconditioning on the reperfusion injury in fatty livers in rats. PLoS ONE. 2013;8(3):e58086.
  • Sarafin A, Rossello-Catafau J, Prats N, et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol. 2002;161:587–601.
  • Koneru B, Dikdan G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transpl. 2002;73:325–330.
  • Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379–1383.
  • Camargo CA Jr, Madden JF, Gao W, et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatol. 1997;26:1513–1520.
  • Peralta C, Prats N, Xaus C, et al. Protective effect of liver ischemic preconditioning on liver and lung injury by hepatic ischemia-reperfusion in the rat. Hepatol. 1999;30:1481–149.
  • Karatzas Th, Neri A-A, Baibaki M-E, et al. Rodent models of hepatic ischemia–reperfusion injury: time and percentage-related pathophysiological mechanisms. J Surg Res. 2014;191(2):399–412.
  • Sydor S, Gu Y, Schlattjan M, et al. Steatosis does not impair liver regeneration after partial hepatectomy. Lab Invest. 2013;93(1):20–30.
  • Clavien PA, Emond J, Vauthey JN, et al. Protection of the liver during hepatic surgery. J Gastrointest Surg. 1994;8:313–327.
  • Selzner N, Selzner M, Odermatt B, et al. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterol. 2003;124:692–700.
  • Serafín A, Fernández-Zabalegui L, Prats N, et al. Ischemic preconditioning: tolerance to hepatic ischemia-reperfusion injury. Histol Histopathol. 2004;19:281–289.
  • Peralta C, Hotter G, Closa D, et al. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion: role of nitric oxide and adenosine. Hepatol. 1997;25:934–937.
  • Chen YW, Li CH, Zhang AQ, et al. Preserving hepatic artery flow during portal triad blood inflow occlusion reduces liver ischemia-reperfusion injury in rats. J Surg Res. 2010;174(1):150–156.
  • Kandilis A, Papadopoulou I, Koskinas J, et al. Liver innervation and hepatic function: new insights. J Surg Res. 2014;194(2):511–519.
  • Peralta C, Bartrons R, Serafin A, et al. Adenosin monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury. Hepatol. 2001;34:1164–1173.
  • Peralta C, Bartrons R, Riera L, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol. 2000;279:G163–71.
  • Serafin A, Rosello´-Catafau J, Prats N, et al. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. AJP 2002;161(2):587–601.
  • Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000;19:2548–2556.
  • Sun Z, Klein AS, Radaeva S, et al. In Vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterol. 2003;125:202–215.
  • Chen RH, Chang MC, Su YH, et al. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem. 1999;274:23013–23019.
  • Kannerup AS, Gronbaek H, Funch-Jensen P, et al. Cytokine changes during warm ischemia and reperfusion of the pig liver with or without preconditioning. Eur Surg Res. 2009;42:216–222.
  • Teoh N, Leclercq I, Pena AD, et al. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatol. 2003;37:118–128.
  • Teoh N, Field J, Sutton J, et al. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Hepatol. 2004;39:412–421.
  • Siriussawakul A, Zaky A, Lang JD. Role of nitric oxide in hepatic ischemia-reperfusion injury. World J Gastroenterol. 2010;16(48):6079–6086.
  • Liu P, Yin R, Nagele R, et al. Inhibition of NOS attenuates peroxynitrite generation, but augments neutrophil infiltration in hepaticischemia-reperfusion. J Pharmacol Exp Ther. 1998;284:1139–1146.
  • Kobayashib H, Nonami T, Kurokawa T, et al. Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver. J Surg Res. 1995;59:772–779.
  • Romanque P, Diaz A, Tapia G. Delayed ischemic preconditioning protects against liver ischemia-reperfusion injury in vivo. Transplant Proc. 2010;42:1569–1575.
  • Phillips L, Toledo AH, Lopez-Neblina F, et al. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22:46–55.
  • Kim YM, de Vera ME, Watkins SC, et al. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem. 1997;272:1402–1411.
  • Yoon S-Y, Kim CY, Han HJ, et al. Protective effect of ischemic post-conditioning against hepatic ischemic reperfusion injury in rat liver. Ann Surg Treat Res. 2015;88(5):241–245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.